The cardiovascular system plays a key role in sepsis, and septic myocardial depression is a common finding associated with increased morbidity and mortality. Myocardial depression during sepsis is not clearly defined, but it can perhaps be best described as a global (systolic and diastolic) dysfunction of both the left and right sides of the heart. The pathogenesis of septic myocardial depression involves a complex mix of systemic (hemodynamic) factors and genetic, molecular, metabolic, and structural alterations. Pulmonary artery catheterization and modern echo-Doppler techniques are important diagnostic tools in this setting. There are no specific therapies for septic myocardial depression, and the cornerstone of management is control of the underlying infectious process (adequate antibiotic therapy, removal of the source) and hemodynamic stabilization (fluids, vasopressor and inotropic agents). In this review, we will summarize the pathogenesis, diagnosis, and treatment of myocardial depression in sepsis. Additional studies are needed in order to improve diagnosis and identify therapeutic targets in septic myocardial dysfunction.

Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment / Antonucci, E; Fiaccadori, Enrico; Donadello, K; Taccone, Fs; Franchi, F; Scolletta, S.. - In: JOURNAL OF CRITICAL CARE. - ISSN 0883-9441. - 29:4(2014), pp. 500-511. [10.1016/j.jcrc.2014.03.028]

Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment.

FIACCADORI, Enrico;
2014-01-01

Abstract

The cardiovascular system plays a key role in sepsis, and septic myocardial depression is a common finding associated with increased morbidity and mortality. Myocardial depression during sepsis is not clearly defined, but it can perhaps be best described as a global (systolic and diastolic) dysfunction of both the left and right sides of the heart. The pathogenesis of septic myocardial depression involves a complex mix of systemic (hemodynamic) factors and genetic, molecular, metabolic, and structural alterations. Pulmonary artery catheterization and modern echo-Doppler techniques are important diagnostic tools in this setting. There are no specific therapies for septic myocardial depression, and the cornerstone of management is control of the underlying infectious process (adequate antibiotic therapy, removal of the source) and hemodynamic stabilization (fluids, vasopressor and inotropic agents). In this review, we will summarize the pathogenesis, diagnosis, and treatment of myocardial depression in sepsis. Additional studies are needed in order to improve diagnosis and identify therapeutic targets in septic myocardial dysfunction.
2014
Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment / Antonucci, E; Fiaccadori, Enrico; Donadello, K; Taccone, Fs; Franchi, F; Scolletta, S.. - In: JOURNAL OF CRITICAL CARE. - ISSN 0883-9441. - 29:4(2014), pp. 500-511. [10.1016/j.jcrc.2014.03.028]
File in questo prodotto:
File Dimensione Formato  
JCritCare2014 septic cardiop.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 603.09 kB
Formato Adobe PDF
603.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2747968
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 228
  • ???jsp.display-item.citation.isi??? 199
social impact